Sleep disturbances are amongst the most prevalent and disabling non-motor symptoms in Parkinson’s disease (PD), encompassing excessive daytime sleepiness (EDS), poor sleep quality, insomnia, and REM sleep behaviour disorder (RBD). The pharmacological evidence base remains fragmented across phenotypes, drug classes, and...
J. B. Canever, Laura Cechinel da Silva, Fernanda Samara Apio et al.· Journal of Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.